News Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offering Continue Reading Previous World title for TOYOTA GAZOO Racing after Fuji winNext Letter to Shareholders and Corporate Update Related Stories News EESystem Triumphs Again: Courts Deem Jason Shurka’s Claims “Baseless” and “Futile” News Autumn Lighting Fair, Outdoor and Tech Light Expo, Eco Expo Asia draw some 62,000 buyers News Saudi Arabia Assumes Chairmanship of INTOSAI News IPO Watch – High-Margin International Business Scales Up Rapidly: Unpacking Hithium Energy Storage’s Global Expansion Ambition Behind its Push for a Hong Kong Listing News CIMC Group Announces the First Three Quarter Results for 2025 News Mobile-health Network Solutions Reports FY2025 Results and Operational Update
